Automated Breast Ultrasound Systems Market Analytical Overview, Growth Factors, Demand, Trends and Forecast to 2031

Rising prevalence of breast cancer across the globe and increasing government initiatives undertaken to encourage breast cancer awareness have significantly fuelled the demand for automated breast ultrasound system, according to ESOMAR-certified Future Market Insights’ (FMI) latest research report. As per the study, the global automated breast ultrasound system market is slated to grow at approximately 10% CAGR over the forthcoming decade.

Key manufacturers are actively focusing on developing faster, accurate and minimal invasive ultrasound breast imaging system. According to report published in National Library of Medicine, integration of mammography with automated breast ultrasound system increased the sensitivity of the system to 99.1%.

The combination drastically improves cancer detection rate among dense breasted women and reduces the interpretation time. Prominent manufacturer GE Healthcare launched a new automated breast ultrasound system named “Invenia” in U.S in October 2018. The main function of the system is to identify the presence of mammographically occult cancer especially in women with dense tissues.

With various other developments on cards, the automated breast ultrasound system market is expected to showcase impressive growth between 2021 and 2031.

“Visibly rising consumer inclination towards radiation free imaging and diagnostics systems is likely to intensify sales of automated breast ultrasound system among diagnostics laboratories,” says the FMI analyst.

Find a comprehensive report summary that describes the market size and forecast along with the research methodology. The Sample report is available in PDF format @ https://www.futuremarketinsights.com/reports/sample/rep-gb-606

Key Takeaways from FMI’s Automated Breast Ultrasound Systems Market Study

  • Increasing government investment to promote breast cancer awareness among women will bolster demand across the U.S.
  • The U.K is expected to experience noteworthy growth as governments and private organizations aim at curbing high mortality rate due to breast cancer.
  • Presence of modern healthcare infrastructure will increase automated breast ultrasound system adoption across Germany
  • Saudi Arabia will offer lucrative opportunities owing to rapid urbanization and emergence of advance diagnostics centers.
  • India is expected to exhibit increasing demand owing to increase in per capita income and to growing incidence of breast cancer among women.
  • Hospitals are expected to lead the market driven by faster accessibility modern tool and availability of skilled professionals.

Competitive Landscape

GE Electric Co., Siemens A.G., Hitachi Ltd., SonoCiné Inc., Koninklijke are some prominent players operating in the automated breast ultrasound system market. They are focusing on improving the accuracy of automated breast ultrasound system for faster assessment of cancer screening in addition to getting government approval for their products.

For instance, Hitachi being the global leader in smart life & eco-friendly systems launched its latest automated breast ultrasound system “SOFIA” capable of scanning and acquiring image of the complete breast.

Koninklijke launched Philips EPIQ and Affiniti ultrasound systems as a part of its automated breast ultrasound system product range. Philips EPIQ is laced with an integrated eL18-4 transducer and employs anatomical intelligence for accurate imaging of the breast with high tissue density.

Talk with our analyst and get the complete information of report now@ https://www.futuremarketinsights.com/ask-question/rep-gb-606

More Insights on the Global Automated Breast Ultrasound Systems Market

In its latest report, FMI offers an unbiased analysis of the global automated breast ultrasound system market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of end user (hospitals, diagnostic imaging laboratories), across seven major regions (North America, Latin America, Western Europe, Eastern Europe, Japan, Asia Pacific excluding Japan,  and Middle East & Africa)

Key Segments Covered

By End User

  • Hospitals
  • Diagnostic Imaging Laboratories
  •  America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Western Europe
    • EU-5
    • BENELUX (Belgium, Netherlands, Luxembourg)
    • NORDIC (Denmark, Finland, Iceland, Norway, Sweden)
    • Rest of Europe

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-606

  • Eastern Europe
    • Poland
    • Russia
    • Rest of Eastern Europe
  • Japan
  • APEJ (Asia Pacific excluding Japan)
    • China
    • India
    • ASEAN Countries
    • Australia & New Zealand
    • Rest of APEJ
  • MEA
    • GCC Countries
    • South Africa
    • Israel
    • Turkey
    • Iran
    • Rest of Middle East & Africa

Explore FMI’s Extensive ongoing Coverage on Healthcare Domain:

Liquid Biopsy Market Forecast : Global liquid biopsy market demand is anticipated to be valued at US$ 1,146 Million in 2022, forecast a CAGR of 13.49% to be valued at US$ 4,126 Million from 2022 to 2032.

Digital Patient Monitoring Systems Market Value : The global Digital Patient Monitoring Systems market is estimated at US$ 96.4 Bn in 2022 and is projected to reach a valuation of US$ 470 Bn by 2032, expanding at a CAGR of 17.2% through the forecast period of 2022-2032.

Breast Cancer Drug Market Analysis : The global breast cancer drug market size is expected to be valued at US$ 10,637.42 Million in 2022.

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs

Leave a comment

Your email address will not be published. Required fields are marked *